I'm LongbridgeAI, I can summarize articles.In Friday's pre-market session, HCW Biologics saw a significant gain of 211.6%, reaching $1.05, following its Q1 earnings report. Other gainers included P3 Health Partners (+21.33%), Intelligent Bio Solutions (+12.65%), and Lifeward (+11.75%). Conversely, Aardvark Therapeutics experienced a sharp decline of 41.8%, while Zentek and Claritev fell by 25.79% and 19.05%, respectively.
Gainers
- HCW Biologics (NASDAQ:HCWB) stock increased by 211.6% to $1.05 during Friday's pre-market session. The market value of their outstanding shares is at $2.2 million. As per the news, the Q1 earnings report came out yesterday.
- P3 Health Partners (NASDAQ:PIII) stock rose 21.33% to $4.89. The company's market cap stands at $13.2 million. As per the news, the Q1 earnings report came out yesterday.
- Intelligent Bio Solutions (NASDAQ:INBS) stock increased by 12.65% to $4.63. The market value of their outstanding shares is at $8.9 million. The company's, Q3 earnings came out 2 days ago.
- Lifeward (NASDAQ:LFWD) shares moved upwards by 11.75% to $7.37. The market value of their outstanding shares is at $18.3 million. The company's, Q1 earnings came out today.
- Sol-Gel Technologies (NASDAQ:SLGL) stock rose 11.38% to $76.5. The market value of their outstanding shares is at $222.8 million.
- MiNK Therapeutics (NASDAQ:INKT) shares rose 9.89% to $11.55. The company's market cap stands at $49.3 million. The company's, Q1 earnings came out today.
Losers
- Aardvark Therapeutics (NASDAQ:AARD) shares decreased by 41.8% to $3.92 during Friday's pre-market session. The market value of their outstanding shares is at $146.8 million.
- Zentek (NASDAQ:ZTEK) stock declined by 25.79% to $0.75. The company's market cap stands at $108.6 million.
- Claritev (NYSE:CTEV) stock declined by 19.05% to $19.0. The company's market cap stands at $400.1 million.
- WORK Medical Tech Gr (NASDAQ:WOK) shares decreased by 17.72% to $1.07.
- Dare Bioscience (NASDAQ:DARE) shares decreased by 14.69% to $2.44. The market value of their outstanding shares is at $41.6 million. As per the press release, Q1 earnings came out yesterday.
- Galmed Pharmaceuticals (NASDAQ:GLMD) stock decreased by 13.43% to $0.57. The company's market cap stands at $4.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.